v3.25.4
Statements of Cash Flows - USD ($)
 6 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Cash flows from operating activities:    
Net Income $ 1,042,224 $ 6,620,992
Adjustments to reconcile net income to net cash used in operating activities:    
Payment of formation costs through issuance of Class B Ordinary Shares 5,402
Payment of operation costs through IPO Promissory Note - related party 30,487
Interest earned on cash and securities held in Trust Account (1,217,835) (7,267,039)
Changes in operating assets and liabilities:    
Prepaid expenses (85,685) 93,914
Due from Sponsor (25,000) (7,590)
Long-term prepaid insurance (86,667) 86,667
Accounts payables and accrued expenses 38,679 83,625
Accrued offering costs (75,264)
Net cash used in operating activities (298,395) (464,695)
Cash flows from investing activities:    
Investment of cash into Trust Account (173,362,500)
Net cash used in investing activities (173,362,500)
Cash flows from financing activities:    
Proceeds from sale of Public Units, net of underwriting discounts paid 169,050,000
Proceeds from sale of Private Placement Units 6,483,750
Repayment of IPO Promissory Note-related party (329,693)
Payment of offering costs (305,961)
Net cash provided by financing activities 174,898,096
Net Change in Cash 1,237,201 (464,695)
Cash - Beginning of period 1,237,201
Cash - End of period 1,237,201 772,506
Supplemental disclosure of noncash investing and financing activities:    
Deferred offering costs included in accrued offering costs 100,264
Deferred offering costs paid through IPO Promissory Note-related party 205,806
Deferred offering costs paid by Sponsor in exchange for issuance of Class B Ordinary Shares 19,598
Accretion of Class A Ordinary Shares to redemption value 13,406,776
Deferred underwriting fee payable $ 6,037,500